医学
社区获得性肺炎
肺炎
优势比
内科学
置信区间
回顾性队列研究
抗生素
肺炎严重指数
共病
逻辑回归
重症监护医学
生物
微生物学
作者
Travis T. Gilbert,Rachel J. Arfstrom,Scott W. Mihalovic,Ala S. Dababneh,Bharath Raj Palraj,Ross Dierkhising,Kristin C. Mara,Sarah Lessard
标识
DOI:10.1097/mjt.0000000000000788
摘要
No difference was seen in 30-day readmissions between CAP patients who received fluoroquinolone monotherapy and those who received β-lactam plus macrolide combination therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI